Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology

Prior treatment

• Subject who has already received chemotherapy or radiotherapy or undergone complete or partial excision of the gynecological pathology of inclusion criterion
• Participation in an interventional study with investigational drug or in the exclusion period of an interventional study.

Other illness

• Recent (\<1 month) or ongoing bacterial or viral infection
• Subject with a diagnosed breast cancer or cancer other than gynecological with the exception of basal cell carcinoma
• Subject with a history of treated cancer within the last 5 years with the exception of basal cell carcinoma

Other

• Known active oral or digestive mycosis
• Evolving oral pathology, symptomatic or obvious
• Known pregnancy
• Known current non-gynecological pelvic pathology
• Subject with significant difficulties reading or writing her language
• Subject unable to comply with study and/or follow-up procedures

• Subject of legal age (according to local legislation) and at least 18 years old
• Subject (and if applicable her legal representative) having dated and signed the informed consent form
• Subject with a medical insurance policy
• Subject presenting to the department:
  • With Symptoms (bleeding and/or pain and/or clinically observed symptom) of one or more of the following pathologies (suspected undergoing diagnostic surgery/biopsy or diagnosed and before any curative treatment of the pathology):
  • Endometriosis
  • Adenomyosis,
  • Ovarian cysts,
  • Fibroids,
  • Ovarian cancer,
  • Cervical cancer,
  • Uterine cancer.
  • Asymptomatic with pap smear positive for cervical dysplasia or cervical cancer and before any curative treatment.
  • Asymptomatic undergoing a pap smear for cervical cancer screening in a gynecological follow-up context.